- Home
- CLNN vs UTSI Comparison
CLNN vs UTSI Comparison
Compare CLNN & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- UTSI
- Stock Information
- Founded
- CLNN 2012
- UTSI 1991
- Country
- CLNN United States
- UTSI China
- Employees
- CLNN N/A
- UTSI N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- UTSI Telecommunications Equipment
- Sector
- CLNN Health Care
- UTSI Telecommunications
- Exchange
- CLNN Nasdaq
- UTSI Nasdaq
- Market Cap
- CLNN 23.1M
- UTSI 24.9M
- IPO Year
- CLNN N/A
- UTSI 2000
- Fundamental
- Price
- CLNN $5.95
- UTSI $2.61
- Analyst Decision
- CLNN Strong Buy
- UTSI
- Analyst Count
- CLNN 5
- UTSI 0
- Target Price
- CLNN $33.00
- UTSI N/A
- AVG Volume (30 Days)
- CLNN 101.0K
- UTSI 7.6K
- Earning Date
- CLNN 08-14-2025
- UTSI 08-29-2025
- Dividend Yield
- CLNN N/A
- UTSI N/A
- EPS Growth
- CLNN N/A
- UTSI N/A
- EPS
- CLNN N/A
- UTSI N/A
- Revenue
- CLNN $286,000.00
- UTSI $9,793,000.00
- Revenue This Year
- CLNN N/A
- UTSI N/A
- Revenue Next Year
- CLNN $2,178.18
- UTSI N/A
- P/E Ratio
- CLNN N/A
- UTSI N/A
- Revenue Growth
- CLNN N/A
- UTSI N/A
- 52 Week Low
- CLNN $2.28
- UTSI $1.84
- 52 Week High
- CLNN $6.90
- UTSI $3.22
- Technical
- Relative Strength Index (RSI)
- CLNN 65.46
- UTSI 56.29
- Support Level
- CLNN $5.12
- UTSI $2.20
- Resistance Level
- CLNN $6.49
- UTSI $2.85
- Average True Range (ATR)
- CLNN 0.63
- UTSI 0.11
- MACD
- CLNN 0.10
- UTSI 0.02
- Stochastic Oscillator
- CLNN 81.76
- UTSI 63.08
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.